These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications. Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753 [TBL] [Abstract][Full Text] [Related]
10. Expression of KIT (CD117) in renal cell carcinoma and renal oncocytoma. Krüger S; Sotlar K; Kausch I; Horny HP Oncology; 2005; 68(2-3):269-75. PubMed ID: 16015044 [TBL] [Abstract][Full Text] [Related]
11. Expression of the glucocorticoid receptor in renal cell neoplasms: an immunohistochemical and quantitative reverse transcriptase polymerase chain reaction study. Yakirevich E; Matoso A; Sabo E; Wang LJ; Tavares R; Meitner P; Morris DJ; Pareek G; Delellis RA; Resnick MB Hum Pathol; 2011 Nov; 42(11):1684-92. PubMed ID: 21531004 [TBL] [Abstract][Full Text] [Related]
12. Mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms: a tissue microarray and quantitative RT-PCR study. Yakirevich E; Morris DJ; Tavares R; Meitner PA; Lechpammer M; Noble L; de Rodriguez AF; Gomez-Sanchez CE; Wang LJ; Sabo E; Delellis RA; Resnick MB Am J Surg Pathol; 2008 Jun; 32(6):874-83. PubMed ID: 18408592 [TBL] [Abstract][Full Text] [Related]
13. KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes. Bellone G; Smirne C; Carbone A; Buffolino A; Scirelli T; Prati A; Solerio D; Pirisi M; Valente G; Nano M; Emanuelli G Int J Oncol; 2006 Oct; 29(4):851-9. PubMed ID: 16964380 [TBL] [Abstract][Full Text] [Related]
14. Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma. Mai KT; Teo I; Belanger EC; Robertson SJ; Marginean EC; Islam S Histopathology; 2008 Feb; 52(3):277-82. PubMed ID: 18081814 [TBL] [Abstract][Full Text] [Related]
15. C-kit overexpression is not associated with KIT gene mutations in chromophobe renal cell carcinoma or renal oncocytoma. Zimpfer A; Janke S; Hühns M; Schneider B; Kundt G; Zettl H; Kilic E; Maruschke M; Hakenberg OW; Erbersdobler A Pathol Res Pract; 2014 Aug; 210(8):521-5. PubMed ID: 24875296 [TBL] [Abstract][Full Text] [Related]
16. Nucleophosmin expression in renal cell carcinoma and oncocytoma. Sari A; Calli A; Altinboga AA; Pehlivan FS; Gorgel SN; Balci U; Ermete M; Dincel C; Cakalagaoglu F APMIS; 2012 Mar; 120(3):187-94. PubMed ID: 22339675 [TBL] [Abstract][Full Text] [Related]
17. KIT expression in chromophobe renal cell carcinoma: comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms. Petit A; Castillo M; Santos M; Mellado B; Alcover JB; Mallofré C Am J Surg Pathol; 2004 May; 28(5):676-8. PubMed ID: 15105658 [TBL] [Abstract][Full Text] [Related]
18. Combined Immunohistochemistry for the "Three 7" Markers (CK7, CD117, and Claudin-7) Is Useful in the Diagnosis of Chromophobe Renal Cell Carcinoma and for the Exclusion of Mimics: Diagnostic Experience from a Single Institution. Zhou J; Yang X; Zhou L; Zhang P; Wang C Dis Markers; 2019; 2019():4708154. PubMed ID: 31737127 [TBL] [Abstract][Full Text] [Related]
19. Underexpression of hepatocyte nuclear factor-1β in chromophobe renal cell carcinoma. Wang CC; Mao TL; Yang WC; Jeng YM Histopathology; 2013 Mar; 62(4):589-94. PubMed ID: 23237209 [TBL] [Abstract][Full Text] [Related]
20. S100A1 and KIT gene expressions in common subtypes of renal tumours. Li G; Gentil-Perret A; Lambert C; Genin C; Tostain J Eur J Surg Oncol; 2005 Apr; 31(3):299-303. PubMed ID: 15780567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]